News Conference News TCT 2012 Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year October 31, 2012
News Conference News TCT 2012 No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT October 26, 2012
News Industry News Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease October 24, 2012
News Conference News TCT 2012 Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology October 24, 2012
News Conference News TCT 2012 Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year October 22, 2012
News Industry News OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2) October 16, 2012
News Industry News OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012 October 16, 2012
News Daily News Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents September 19, 2012
News Daily News SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis Yael L. Maxwell September 07, 2012
News Conference News ESC 2012 Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis Caitlin E. Cox August 29, 2012
News Conference News ESC 2012 OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon Caitlin E. Cox August 29, 2012
News Industry News Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent August 20, 2012
News Daily News Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease Caitlin E. Cox August 16, 2012
News Daily News RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year L.A. McKeown July 30, 2012